Sr CRA II (Cape Town) Sponsor dedicated Syneos Health® is a leading fully-integrated life sciences services organization built to accelerate customer success. We partner with innovators at every point across the drug development and commercialization continuum,
Sr CRA I / II (preferred base Cape Town) Sponsor dedicated Syneos Health® is a leading fully-integrated life sciences services organization built to accelerate customer success. We partner with innovators at every point across the drug
Sr CRA I / II Location: Cape Town (preferred base) Job Responsibilities Performs site qualification, site initiation, interim monitoring, site management and close‑out visits (performed on‑site or remotely) ensuring regulatory, ICH‑GCP and/or Good Pharmacoepidemiology Practices (GPP)
Job Responsibilities Performs site qualification, site initiation, interim monitoring, site management and close‑out visits (performed on‑site or remotely) ensuring regulatory, ICH‑GCP and/or Good Pharmacoepidemiology Practices (GPP) and protocol compliance. Uses judgement and experience to evaluate overall
Updated: Today Location: Bloemfontein, EC, South Africa Job ID: Syneos Health is a leading fully integrated biopharmaceutical solutions organization built to accelerate customer success. Job Responsibilities Performs site qualification, site initiation, interim monitoring, site management and
Who We’re Looking For Not a corporate executive. Not a deck-polisher. Not someone looking for a “Head of Ops” title with guardrails. We’re looking for a builder–operator. A systems thinker who thrives in ambiguity. A calm
Sr CRA II / Lead CRA (Cape Town) Sponsor dedicated Updated: Today Location: Bloemfontein, EC, South Africa Job ID: Job Title: Sr CRA II / Lead CRA (Cape Town) Sponsor dedicated Job Responsibilities Performs site qualification,
Sr CRA I / II Location: Cape Town (preferred base) Job Responsibilities Performs site qualification, site initiation, interim monitoring, site management and close‑out visits (performed on‑site or remotely) ensuring regulatory, ICH‑GCP and/or Good Pharmacoepidemiology Practices (GPP)